Orcinol glucoside produces antidepressant effects by blocking the behavioural and neuronal deficits caused by chronic stress

European Neuropsychopharmacology

Volumn 24, Issue 1, 2014, Pages 172-180

  Ge, Jin Fang ^a   Gao, Wen Chao ^a   Cheng, Wen Ming ^a   Lu, Wei Li ^a   Tang, Jie ^a   Peng, Lei ^a   Li, Ning ^a   Chen, Fei Hu ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; Brain derived neurotrophic factor (BDNF); Extracellular signal regulated kinase (ERK); Hypothalamic pituitary adrenal (HPA) axis; Orcinol glucoside

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; GLUCOSIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; ORCINOL GLUCOSIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CHRONIC STRESS; CHRONIC UNPREDICTABLE MILD STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG MECHANISM; FORCED SWIM TEST; HIPPOCAMPUS; HYPERACTIVITY; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST;

ANTIDEPRESSANT; BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF); EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK); HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS; ORCINOL GLUCOSIDE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD PREFERENCES; GLUCOSIDES; HINDLIMB SUSPENSION; MALE; MAP KINASE SIGNALING SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RESORCINOLS; STRESS, PSYCHOLOGICAL; SUCROSE; SWEETENING AGENTS; SWIMMING;

EID: 84892483211     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.05.007     Document Type: Article

References (54)

1. Adams S., Heckard D., Hassell J., Uphouse L. Factors influencing fluoxetine-induced sexual dysfunction in female rats. Behav. Brain Res. 2012, 235:73-81.
2. Bafna A.R., Mishra S.H. Immunostimulatory effect of methanol extract of Curculigo orchioides on immunosuppressed mice. J. Ethnopharmacol. 2006, 104:1-4.
3. Bai M., Zhu X., Zhang Y., Zhang S., Zhang L., Xue L., Yi J., Yao S., Zhang X. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One 2012, 7:e46921.
4. Baldessarini R.J. The basis for amine hypotheses in affective disorders. A critical evaluation. Arch. Gen. Psychiatry 1975, 32:1087-1093.
5. Brenes J.C., Fornaguera J. The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum. Behav. Brain Res. 2009, 198:199-205.
6. Brenes Saenz J.C., Villagra O.R., Fornaguera Trias J. Factor analysis of forced swimming test, sucrose preference test and open field test on enriched, social and isolated reared rats. Behav. Brain Res. 2006, 169:57-65.
7. Carlezon W.A., Pliakas A.M., Parow A.M., Detke M.J., Cohen B.M., Renshaw P.F. Antidepressant-like effects of cytidine in the forced swim test in rats. Biol. Psychiatry 2002, 51:882-889.
8. Cassano P., Fava M. Tolerability issues during long-term treatment with antidepressants. Ann. Clin. Psychiatry 2004, 16:15-25.
9. Chauhan N.S., Rao Ch, V., Dixit V.K. Effect of Curculigo orchioides rhizomes on sexual behaviour of male rats. Fitoterapia 2007, 78:530-534.
10. Chen X.N., Meng Q.Y., Bao A.M., Swaab D.F., Wang G.H., Zhou J.N. The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders. Biol. Psychiatry 2009, 66:832-839.
11. Cieslik K., Sowa-Kucma M., Ossowska G., Legutko B., Wolak M., Opoka W., Nowak G. Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment. Pharmacol. Rep. 2011, 63:537-543.
12. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 2005, 29:571-625.
13. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005, 29:547-569.
14. Der-Avakian A., Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012, 35:68-77.
15. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
16. Elfving B., Plougmann P.H., Muller H.K., Mathe A.A., Rosenberg R., Wegener G. Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int. J. Neuropsychopharmacol. 2010, 13:563-572.
17. Evans J., Sun Y., McGregor A., Connor B. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology 2012, 63:1315-1326.
18. First M., Gil-Ad I., Taler M., Tarasenko I., Novak N., Weizman A. The effects of reboxetine treatment on depression-like behavior, brain neurotrophins, and ERK expression in rats exposed to chronic mild stress. J. Mol. Neurosci. 2012, September 12 [Epub ahead of print] PMID:22968760.
19. Garza J.C., Guo M., Zhang W., Lu X.Y. Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling. Mol. Psychiatry 2012, 17:790-808.
20. Hansson A.C., Sommer W., Rimondini R., Andbjer B., Stromberg I., Fuxe K. c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J. Neurosci. 2003, 23:6013-6022.
21. Holsboer F., Ising M. Stress hormone regulation: biological role and translation into therapy. Annu. Rev. Psychol. 2010, 61(81-109):C101-111.
22. Ioannidis J.P. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?. Philos. Ethics Humanit. Med. 2008, 3:14.
23. Jiang W., Fu F., Tian J., Zhu H., Hou J. Curculigoside A attenuates experimental cerebral ischemia injury in vitro and vivo. Neuroscience 2011, 192:572-579.
24. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
25. Kumamaru E., Numakawa T., Adachi N., Kunugi H. Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB. FEBS Lett. 2011, 585:3224-3228.
26. Kumamaru E., Numakawa T., Adachi N., Yagasaki Y., Izumi A., Niyaz M., Kudo M., Kunugi H. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol. Endocrinol. 2008, 22:546-558.
27. Kunugi H., Hori H., Adachi N., Numakawa T. Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry Clin. Neurosci. 2010, 64:447-459.
28. Li N., He X., Zhang Y., Qi X., Li H., Zhu X., He S. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine. Int. J. Neuropsychopharmacol. 2011, 14:1091-1098.
29. Li N, Jia Z.Y., Liu AQ, Zhou J YQ Study on the chemical constituents of Curculigo orchioides. Nat. Prod. Res. Dev. 2003, 15(3):208-211.
30. Lin H., Geng X., Dang W., Wu B., Dai Z., Li Y., Yang Y., Zhang H., Shi J. Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex. Brain Res. 2012, 1447:119-125.
31. Paizanis E., Renoir T., Lelievre V., Saurini F., Melfort M., Gabriel C., Barden N., Mocaer E., Hamon M., Lanfumey L. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int. J. Neuropsychopharmacol. 2010, 13:759-774.
32. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
33. Qi X., Lin W., Li J., Li H., Wang W., Wang D., Sun M. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol. Dis. 2008, 31:278-285.
34. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22:659-661.
35. Reneric J.P., Bouvard M., Stinus L. In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed. Eur. Neuropsychopharmacol. 2002, 12:159-171.
36. Rygula R., Abumaria N., Domenici E., Hiemke C., Fuchs E. Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav. Brain Res. 2006, 174:188-192.
37. Schatzberg A.F. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J. Clin. Psychiatry 2007, 68(Suppl. 8):26-34.
38. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 1995, 15:1768-1777.
39. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005, 4:141-194.
40. Takano K., Yamasaki H., Kawabe K., Moriyama M., Nakamura Y. Imipramine induces brain-derived neurotrophic factor mRNA expression in cultured astrocytes. J. Pharmacol. Sci. 2012, 120:176-186.
41. Thiel C.M., Huston J.P., Schwarting R.K. Hippocampal acetylcholine and habituation learning. Neuroscience 1998, 85:1253-1262.
42. Tian Z., Yu W., Liu H.B., Zhang N., Li X.B., Zhao M.G., Liu S.B. Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro. Food Chem. Toxicol. 2012, 50:4010-4015.
43. Trivedi M.H., Fava M., Wisniewski S.R., Thase M.E., Quitkin F., Warden D., Ritz L., Nierenberg A.A., Lebowitz B.D., Biggs M.M., Luther J.F., Shores-Wilson K., Rush A.J. Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. 2006, 354:1243-1252.
44. Ubhi K., Inglis C., Mante M., Patrick C., Adame A., Spencer B., Rockenstein E., May V., Winkler J., Masliah E. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of alpha-synucleinopathy. Exp. Neurol. 2012, 234:405-416.
45. Uher R., Farmer A., Henigsberg N., Rietschel M., Mors O., Maier W., Kozel D., Hauser J., Souery D., Placentino A., Strohmaier J., Perroud N., Zobel A., Rajewska-Rager A., Dernovsek M.Z., Larsen E.R., Kalember P., Giovannini C., Barreto M., McGuffin P., Aitchison K.J. Adverse reactions to antidepressants. Br. J. Psychiatry 2009, 195:202-210.
46. van der Watt G., Laugharne J., Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr. Opin. Psychiatry 2008, 21:37-42.
47. Wang S.S., Yan X.B., Hofman M.A., Swaab D.F., Zhou J.N. Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci. Bull. 2010, 26:297-303.
48. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 1987, 93:358-364.
49. Wu L.M., Han H., Wang Q.N., Hou H.L., Tong H., Yan X.B., Zhou J.N. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 2007, 32:2500-2510.
50. Wu Q., Fu D.X., Hou A.J., Lei G.Q., Liu Z.J., Chen J.K., Zhou T.S. Antioxidative phenols and phenolic glycosides from Curculigo orchioides. Chem. Pharm. Bull. (Tokyo) 2005, 53:1065-1067.
51. Wu X.Y., Li J.Z., Guo J.Z., Hou B.Y. Ameliorative effects of curculigoside from Curculigo orchioides Gaertn on learning and memory in aged rats. Molecules 2012, 17:10108-10118.
52. Xie Y., Huang X., Hu S.Y., Zhang Y.J., Wang Y., Qiu X.J., Ren P., Fan R., Zhang C.H., Xie W.B., Ji H., He J., Chen X., Xie L., Liu Z.Q., Zhou H.H. The involvement of AMPA-ERK1/2-BDNF pathway in the mechanism of new antidepressant action of prokinetic meranzin hydrate. Amino Acids 2013, 44:413-422.
53. Yamawaki Y., Fuchikami M., Morinobu S., Segawa M., Matsumoto T., Yamawaki S. Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J. Biol. Psychiatry 2012, 13:458-467.
54. Zhang L., Xu T., Wang S., Yu L., Liu D., Zhan R., Yu S.Y. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice. Behav. Brain Res. 2012, 235:67-72.